Top insurers and drugmakers spar over costly most cancers treatments
A few most cancers patients and their insurers are seeing their payments for chemotherapy bouncesharply, reflecting elevated drug expenses and hospitals’ push to shop for oncologists’ practices and theninvoice at higher fees. patients say, “‘I’ve been dealt with with Herceptin for breast cancer for numerous years and it was usually$five,000 ... Read More »